共 31 条
[1]
Stein P.D., Matta F., Epidemiology and incidence: the scope of the problem and risk factors for development of venous thromboembolism, Crit Care Clin, 27, pp. 907-932, (2011)
[2]
Go A.S., Mozaffarian D., Roger V.L., Et al., American heart association statistics committee and stroke statistics subcommittee. Heart disease and stroke statistics – 2013 update: a report from the American heart association, Circulation, 127, 1, pp. 6-245, (2013)
[3]
Barritt D.W., Jordan S.C., Anticoagulant drugs in the treatment of pulmonary embolism: a controlled trial, Lancet, 1, pp. 1309-1312, (1960)
[4]
Carson J.L., Kelley M.A., Duff A., Et al., The clinical course of pulmonary embolism, N Engl J Med, 326, 19, pp. 1240-1245, (1992)
[5]
Meyer B., Vicaut E., Danays T., Et al., Fibrinolysis for patients with intermediate-risk pulmonary embolism, N Engl J Med, 370, pp. 1402-1411, (2014)
[6]
Douma R.A., Kamphuisen P.W., Buller H.R., Acute pulmonary embolism. Part 1: epidemiology and diagnosis, Nat Rev Cardiol, 7, pp. 585-596, (2010)
[7]
LaMori J.C., Shoheiber O., Mody S.H., Bookhart B.K., Inpatient resource Use and cost burden of deep vein thrombosis and pulmonary embolism in the United States, Clin Ther, 37, pp. 62-70, (2015)
[8]
Weiner R.S., Ouellette D.R., Diamond E., An official American Thoracic Society/American College of Chest Physicians policy statement: the Choosing Wisely top five list in adult pulmonary medicine, 145, 6, pp. 1383-1391, (2014)
[9]
Venkatesh A.K., Kline J.A., Courtney D.M., Et al., Evaluation of pulmonary embolism in the emergency department and consistency with a national quality measure: quantifying the opportunity for improvement, Arch Intern Med, 172, 13, pp. 1028-1032, (2012)
[10]
Jaff M.R., McMurtry S., Archer S.L., American Heart Association Council on Cardiopulmonary, Critical Care, Perioperative and Resuscitation, American Heart Association Council on Peripheral Vascular Disease, American Heart Association Council on Arteriosclerosis, Thrombosis and Vascular Biology. Management of massive and submassive pulmonary embolism, iliofemoral deep venous thrombosis, and chronic thromboembolic pulmonary hypertension: a scientific statement from the American Heart Association,